These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1300884)
21. von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients. Huser B; Lämmle B; Landmann J; Tran TH; Oberholzer M; Marbet GA; Thiel G; Mihatsch MJ; Duckert F Clin Nephrol; 1990 Nov; 34(5):214-22. PubMed ID: 2125251 [TBL] [Abstract][Full Text] [Related]
22. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250 [TBL] [Abstract][Full Text] [Related]
23. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation. Min DI; Perry PJ; Chen HY; Hunsicker LG Pharmacotherapy; 1998; 18(2):282-7. PubMed ID: 9545147 [TBL] [Abstract][Full Text] [Related]
24. [The differential diagnosis and therapy of hemolytic anemias after the transplantation of solid organs]. von Appen K Urol Nefrol (Mosk); 1998; (5):41-3. PubMed ID: 9820048 [TBL] [Abstract][Full Text] [Related]
25. Acute vascular rejection with hemolytic uremic syndrome in kidneys from non-heart-beating donors: associated with secondary grafts and early cyclosporine treatment? Schlumpf R; Candinas D; Weder W; Röthlin M; Zollinger A; Bleisch J; Retsch M; Largiadèr F Transplant Proc; 1993 Feb; 25(1 Pt 2):1518-21. PubMed ID: 8442172 [No Abstract] [Full Text] [Related]
26. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss? He X; Johnston A Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323 [TBL] [Abstract][Full Text] [Related]
28. Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A. Chen WS; Young AH; Wang HP; Huang DF Rheumatol Int; 2009 May; 29(7):821-4. PubMed ID: 19156422 [TBL] [Abstract][Full Text] [Related]
29. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation. Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052 [TBL] [Abstract][Full Text] [Related]
31. Graft failure due to hemolytic uremic syndrome recurrence. Iaria G; Iorio B; Anselmo A; De Luca L; Tariciotti L; Ielpo B; Muzi F; Lucchesi C; D'Andria D; Orlando G; Del Poeta G; Poggi E; Piazza A; Tisone G Transplant Proc; 2006 May; 38(4):1020-1. PubMed ID: 16757250 [TBL] [Abstract][Full Text] [Related]
32. Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases. Beaufils H; de Groc F; Gubler MC; Wechsler B; Le Hoang P; Baumelou A; Chomette G; Jacobs C Clin Nephrol; 1990 Oct; 34(4):157-62. PubMed ID: 2257701 [TBL] [Abstract][Full Text] [Related]
33. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine. Romagnoli J; Citterio F; Nanni G; Favi E; Tondolo V; Spagnoletti G; Salerno MP; Castagneto M Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255 [TBL] [Abstract][Full Text] [Related]
34. Hemolytic anemia after renal transplantation: analysis of case reports. Debska-Slizień A; Chamienia A; Król E; Zdrojewski Z; Pirski I; Zadrozny D; Sledziński Z; Rutkowski B Transplant Proc; 2003 Sep; 35(6):2233-7. PubMed ID: 14529899 [TBL] [Abstract][Full Text] [Related]
35. Possible hemolytic uremic syndrome in three cats after renal transplantation and cyclosporine therapy. Aronson LR; Gregory C Vet Surg; 1999; 28(3):135-40. PubMed ID: 10338157 [TBL] [Abstract][Full Text] [Related]
36. The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. Kaufman DB; Kaplan B; Kanwar YS; Abecassis M; Stuart FP Transplantation; 1995 Jun; 59(12):1737-9. PubMed ID: 7541579 [No Abstract] [Full Text] [Related]